FibroGen Inc (NASDAQ: FGEN)
$1.15
+0.0850 ( +8.02% ) 1.5M
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.
Market Data
Open
$1.15
Previous close
$1.06
Volume
1.5M
Market cap
$113.40M
Day range
$1.03 - $1.16
52 week range
$0.33 - $2.93
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jun 06, 2024 |
4 | Insider transactions | 1 | Jun 06, 2024 |
4 | Insider transactions | 1 | Jun 06, 2024 |
4 | Insider transactions | 1 | Jun 06, 2024 |
8-k | 8K-related | 12 | May 06, 2024 |
10-q | Quarterly Reports | 80 | May 06, 2024 |
4 | Insider transactions | 1 | May 02, 2024 |
ars | Annual reports | 1 | Apr 25, 2024 |
3 | Insider transactions | 2 | Apr 24, 2024 |
def | Proxies and info statements | 20 | Apr 24, 2024 |